Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

Mostrar otras versiones (1)

The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID19 disease has generated a need for assays to rapidly and conveniently measure the antiviral activity of SARSCoV-2-specific antibodies. Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Fabian, Weisblum, Yiska, Muecksch, Frauke, Hoffmann, Hans-Heinrich, Michailidis, Eleftherios, Lorenzi, Julio C. C., Mendoza, Pilar, Rutkowska, Magdalena, Bednarski, Eva, Gaebler, Christian, Agudelo, Marianna, Cho, Alice, Wang, Zijun, Gazumyan, Anna, Cipolla, Melissa, Caskey, Marina, Robbiani, Davide F., Nussenzweig, Michel C., Rice, Charles M., Hatziioannou, Theodora, Bieniasz, Paul D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302213/
https://www.ncbi.nlm.nih.gov/pubmed/32577658
http://dx.doi.org/10.1101/2020.06.08.140871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302213/
https://www.ncbi.nlm.nih.gov/pubmed/32577658
http://dx.doi.org/10.1101/2020.06.08.140871

Ejemplares similares